BTIG to Host 2017 Medical Technology, Life Science and Diagnostic Tools Conference in Snowbird, Utah – Event to Attract Over 70 Industry-Leading Healthcare Companies

New York – February 9, 2017 – BTIG, LLC announced today that it will host the 2017 BTIG Medical Technology, Life Science and Diagnostic Tools Conference in Snowbird, Utah from February 28, 2017 through March 2, 2017. The annual event brings together management teams from more than 70 innovative healthcare companies with BTIG’s institutional client base.

The conference will be co-hosted by Sean Lavin, MD, BTIG Medical Technology Analyst, and Karen Koski, Life Science and Diagnostic Tools Analyst. “The 2017 conference will offer insight into the evolving healthcare landscape and will provide access to many sought after management teams. Leading, established multinationals and emerging growth companies will be in attendance, and participants will have an opportunity to evaluate the market and identify potential investments,” said Karen Blando, Director of Research at BTIG.

Produced by BTIG’s Corporate Access Group, the conference is part of a growing product offering. “The conference hosts both established and emerging healthcare companies each year,” said Sean Lavin. “We believe investors value the breadth of the attending companies and the differentiated venue.”

For more information about the conference, including a list of presenting companies, please contact a BTIG representative or email [email protected].

About BTIG
BTIG is a global financial services firm specializing in institutional trading, investment banking, research and related brokerage services. With an extensive global footprint and more than 500 employees, BTIG, LLC and its affiliates operate out of 14 cities throughout the U.S., and in Europe, Asia and Australia. BTIG offers execution, expertise and insights for equities, equity derivatives, ETFs and fixed income (futures, commodities, foreign exchange, interest rates, credit as well as convertible and preferred securities). The firm’s core capabilities include global execution, portfolio, electronic and outsource trading, transition management, investment banking, prime brokerage, capital introduction, corporate access, research and strategy, commission management and more. Disclaimer:

Media Contacts:
Jill Gordon
212.279.3115, ext. 226 

[email protected]

Amanda Gold

[email protected]